{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:42:27Z","timestamp":1790523747559,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008708.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000}}],"reference-count":64,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008708.pub5","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T16:35:02Z","timestamp":1619022902000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hematopoietic stem cell transplantation for people with \u03b2-thalassaemia"],"prefix":"10.1002","volume":"2021","author":[{"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Cellular Therapy; St. Jude Children's Research Hospital; Memphis Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanitha A","family":"Jagannath","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; American Mission Hospital; Manama Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latika","family":"Puri","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital; Memphis Tennessee 38105 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD008708.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.bmt.1705151","article-title":"Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome","volume":"36","author":"Chandy","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD008708.pub5-BIB0002|cit2","first-page":"127a","article-title":"Plasma busulfan levels influence rejection in bone marrow transplantation for homozygous beta thalassaemia","volume":"92","author":"Dennison","year":"1998","journal-title":"Blood"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD008708.pub5-BIB0003|cit3","first-page":"128a","article-title":"Correlation of hepatic glutathione S-transferase levels with busulfan pharmacokinetics in children with homozygous beta thalassemia undergoing bone marrow transplantation","volume":"92","author":"Poonkuzhali","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD008708.pub5-BIB0004|cit4","first-page":"264","article-title":"Glutathione S-transferase activity influences busulfan pharmacokinetics in patients with beta thalassemia major undergoing bone marrow transplantation","volume":"29","author":"Poonkuzhali","year":"2001","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.1002\/14651858.CD008708.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bmt.1701814","article-title":"Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation","volume":"24","author":"Poonkuzhali","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD008708.pub5-BIB0007|cit7","article-title":"Oral versus intravenous busulfan in bone marrow transplantation for thalassemia","volume":"102","author":"Dennison","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD008708.pub5-BIB0008|cit8","first-page":"300","article-title":"Intravenous chelation therapy during transplantation for thalassemia","volume":"80","author":"Gaziev","year":"1995","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD008708.pub5-BIB0009|cit9","first-page":"107","article-title":"Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation","volume":"58","author":"Irfan","year":"2008","journal-title":"Journal of the Pakistan Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD008708.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/chim.15057","article-title":"Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies","volume":"2","author":"Andreani","year":"2011","journal-title":"Chimerism"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD008708.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/bmt.2015.293","article-title":"Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010","volume":"51","author":"Baronciani","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1002\/14651858.CD008708.pub5-BIB0013|cit13","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"issue":"6","key":"10.1002\/14651858.CD008708.pub5-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbmt.2010.09.011","article-title":"Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation","volume":"17","author":"Caocci","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1002\/14651858.CD008708.pub5-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/ajh.24898","article-title":"Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment","volume":"92","author":"Caocci","year":"2017","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0016|cit16","volume-title":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)","author":"Cappellini","year":"2014"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/bmt.2008.165","article-title":"Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT","volume":"42","author":"Cheuk","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1002\/14651858.CD008708.pub5-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/hum.2018.178","article-title":"Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation","volume":"30","author":"Coquerelle","year":"2019","journal-title":"Hum Gene Ther"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0019|cit19","unstructured":"Deeks J Higgins JP Altman D Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"7","key":"10.1002\/14651858.CD008708.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ajh.21175","article-title":"Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation","volume":"83","author":"Di Bartolomeo","year":"2008","journal-title":"American Journal of Hematology"},{"issue":"10","key":"10.1002\/14651858.CD008708.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-4632.2009.04176.x","article-title":"Skin diseases in patients with beta-thalassemia major","volume":"48","author":"Dogramaci","year":"2009","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0023|cit23","unstructured":"European Medicines Agency Zynteglo www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zynteglo"},{"issue":"1","key":"10.1002\/14651858.CD008708.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbmt.2012.08.005","article-title":"French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions","volume":"19","author":"Galambrun","year":"2013","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD008708.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5812\/ircmj.1915","article-title":"Twenty years of experience on stem cell transplantation in Iran","volume":"15","author":"Ghavamzadeh","year":"2013","journal-title":"Iranian Red Crescent medical journal"},{"issue":"7414","key":"10.1002\/14651858.CD008708.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0027|cit27","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"2","key":"10.1002\/14651858.CD008708.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.anpedi.2012.12.002","article-title":"Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease","volume":"79","author":"Hladun","year":"2013","journal-title":"Anales de Pediatria"},{"issue":"6","key":"10.1002\/14651858.CD008708.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbmt.2006.02.008","article-title":"Outcomes of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia","volume":"12","author":"Hongeng","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD008708.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/pbc.24493","article-title":"Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major","volume":"60","author":"Hussein","year":"2013","journal-title":"Pediatric Blood & Cancer"},{"issue":"8","key":"10.1002\/14651858.CD008708.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.2010.05543.x","article-title":"Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia","volume":"1202","author":"Isgro","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"9429","key":"10.1002\/14651858.CD008708.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(04)16628-2","article-title":"Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children","volume":"364","author":"Jacobsohn","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0034|cit34","doi-asserted-by":"crossref","unstructured":"La Nasa G Argiolu F Giardini C Pession A Fagioli F Caocci G Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group Annals of the New York Academy of Sciences 2005 1054 186 95 16339665","DOI":"10.1196\/annals.1345.023"},{"issue":"13","key":"10.1002\/14651858.CD008708.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2013-05-502658","article-title":"Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia","volume":"122","author":"La Nasa","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0036|cit36","first-page":"691","article-title":"[Pretreatment doses of antithymocyte globubin-fresenius for allogeneic hematopoietic stem cell transplantation for beta-thalassemia major]","volume":"32","author":"Li","year":"2012","journal-title":"Journal of Southern Medical University"},{"issue":"6","key":"10.1002\/14651858.CD008708.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood-2013-03-489112","article-title":"Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling","volume":"122","author":"Locatelli","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD008708.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood.V93.4.1164","article-title":"Bone marrow transplantation in adult thalassemic patients","volume":"93","author":"Lucarelli","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Lucarelli G Advances in the allogeneic transplantation for thalassemia Blood Reviews 2008 22 2 53 63 18039551","DOI":"10.1016\/j.blre.2007.10.001"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"a011825","DOI":"10.1101\/cshperspect.a011825","article-title":"Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia","volume":"2","author":"Lucarelli","year":"2012","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"6","key":"10.1002\/14651858.CD008708.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"10.1002\/14651858.CD008708.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199907083410207","article-title":"The beta-thalassemias","volume":"341","author":"Olivieri","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008708.pub5-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007001.pub5","article-title":"Hematopoietic stem cell transplantation for people with sickle cell disease","author":"Oringanje","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008708.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.moh.0000143701.88042.d9","article-title":"HLA matching in allogeneic stem cell transplantation","volume":"11","author":"Petersdorf","year":"2004","journal-title":"Current Opinion in Hematology"},{"issue":"20","key":"10.1002\/14651858.CD008708.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMra1404415","article-title":"The \u03b1-thalassemias","volume":"371","author":"Piel","year":"2014","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1002\/14651858.CD008708.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","article-title":"How I treat thalassemia","volume":"118","author":"Rachmilewitz","year":"2011","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0047|cit47","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2011"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1196\/annals.1345.010","article-title":"Progress toward the genetic treatment of the beta-thalassemias","volume":"1054","author":"Sadelain","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.med.56.082103.104718","article-title":"New strategies in the treatment of the thalassemias","volume":"56","author":"Schrier","year":"2005","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0050|cit50","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings\u2019 tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0051|cit51","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD008708.pub5-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbmt.2017.01.009","article-title":"Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation","volume":"23","author":"Shenoy","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/pr.2011.s2.e13","article-title":"T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients","volume":"3 Suppl 2","author":"Sodani","year":"2011","journal-title":"Pediatric Reports"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1472-6963-13-45","article-title":"Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program","volume":"13","author":"Sruamsiri","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0055|cit55","unstructured":"Sterne JA Effer M Moher D Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ajh.23405","article-title":"Treating iron overload in patients with non-transfusion-dependent thalassemia","volume":"88","author":"Taher","year":"2013","journal-title":"American Journal of Hematology"},{"issue":"8292","key":"10.1002\/14651858.CD008708.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(82)90319-1","article-title":"Marrow transplantation for thalassaemia","volume":"2","author":"Thomas","year":"1982","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD008708.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1702518","article-title":"Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease","volume":"26","author":"Besien","year":"2000","journal-title":"Bone marrow transplantation"},{"issue":"4","key":"10.1002\/14651858.CD008708.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nature Reviews Genetics"},{"key":"10.1002\/14651858.CD008708.pub5-BIB0060|cit60","volume-title":"The Thalassaemia Syndromes","author":"Weatherall","year":"2002"},{"issue":"5","key":"10.1002\/14651858.CD008708.pub5-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/trf.13513","article-title":"Healthcare costs and outcomes of managing \u03b2-thalassemia major over 50 years in the United Kingdom","volume":"56","author":"Weidlich","year":"2016","journal-title":"Transfusion"},{"issue":"10","key":"10.1002\/14651858.CD008708.pub5-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008708.pub2","article-title":"Hematopoietic stem cell transplantation for people with \u00df-thalassaemia major","author":"Jagannath","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD008708.pub5-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008708.pub3","article-title":"Hematopoietic stem cell transplantation for people with \u00df-thalassaemia major","author":"Jagannath","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD008708.pub5-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008708.pub4","article-title":"Hematopoietic stem cell transplantation for people with \u00df-thalassaemia major","author":"Jagannath","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T08:46:34Z","timestamp":1754297194000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008708.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008708.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}